Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center (high importance). - Updated version to v3.2.0; removed v3.1.0 reference.SummaryDifference4%

- Check32 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.1%

- Check47 days agoChange DetectedPage revision bumped from v3.0.1 to v3.0.2. The old revision tag and the 'Back to Top' element were removed as minor UI cleanup.SummaryDifference0.3%

- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%

- Check61 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of new MedlinePlus related topics on cancer. Notably, the previous topics on lung cancer have been removed.SummaryDifference5%

- Check75 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.